August 3, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026, inclusive. The lawsuit is filed in the United States District Court for the District of Connecticut and is captioned Taher Basma v. GeneDx Holdings Corp., No. 26-cv-00880 (D. Conn.). Investors have until August 3, 2026, to file for lead plaintiff status.

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired GeneDx common stock and have lost money on your investment, you are encouraged to contact KTMC attorney Jonathan Naji, Esq. at:

[phone]
[e-mail]
https://www.ktmc.com/wgs-genedx-holdings-corp-class-action-lawsuit?utm ...

There is no cost or obligation to speak with an attorney.

GENEDX HOLDINGS CORP. CLASS ACTION LAWSUIT – COMPLAINT ALLEGATION SUMMARY:
GeneDx provides genetic testing services for diagnosing pediatric and rare diseases. The class period begins on April 16, 2025, when GeneDx announced that it entered into an agreement worth up to $51 million to acquire Fabric Genomics (“Fabric”), a firm focused on AI-driven genomic interpretation. As part of the deal, WGS would pay up to $33 million cash up front, with total consideration up to $51 million. As part of the announcement of the acquisition, GeneDx stated that it would expand GeneDx’s addressable market with several scalable revenue streams. GeneDx went on to tout that Fabric’s “software transforms static data into a dynamic, recurring revenue-generating platform—driving growth through software margins and high-leverage interpretation services across geographies and clinical use cases.”

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) Fabric faced significant problems with its viability; and (2) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Schreibe Deinen Kommentar